News

This Phase IB trial is focused on finding the optimal dosage for the formulation of Oramed’s proprietary oral insulin delivery technology. The study utilizes healthy human volunteers in

The US District Court of New Jersey has postponed the trial date. The general terms and status of the anticipated settlement will not be disclosed by either party

The primary objective of the multi-center clinical trial is to assess the overall tumor response rate in non-small cell lung cancer (NSCLC) patients treated with the combination of

The primary objective of this trial is to assess the efficacy, measured as first-year height velocity, and safety of three different combination regimens of growth hormone and IGF-1

The new product is a combination therapy that joins together both Hadasit and BWH/HMS intellectual property. This is the first official cooperation between Hadasit, Hadassah, Harvard Medical School

The Reliant monitor is powered by Cheetah’s unique, patented Bioreactance technology, which has been used effectively in over 1,000 patients in various clinical settings including hemodynamic monitoring, heart

This was the last step necessary for Jiangling to be eligible for Good Manufacturing Practices (GMP) certification, a standard required in China to produce pharmaceuticals or their ingredients.

Pursuant to the terms of the distribution agreement BodyTel granted FourMed the right to exclusively market the products of BodyTel in the eight Arabian countries, with the United

The agreement allows Caldera Medical access to the transobturator method for the surgical treatment of stress incontinence. The agreement also allows Caldera Medical to protect the uniqueness of